Lv44
780 积分 2023-02-02 加入
D3S-001 in advanced solid tumors with KRASG12C mutations: a phase 1 trial
5小时前
已完结
Safety, pharmacokinetics and pharmacodynamics of HRS‐7535, a novel oral small molecule glucagon‐like peptide‐1 receptor agonist, in healthy participants: A phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose, and food effect trial
9天前
已完结
Consensus statement on the use of systemic therapies in pancreatic ductal adenocarcinoma in Asia
12天前
已关闭
Impact of Sotorasib, a KRAS G12C Inhibitor, on the Pharmacokinetics and Therapeutic Window of Digoxin, a P‐Glycoprotein Substrate
15天前
已完结
Effect of Food on the Pharmacokinetic Characteristics of a Single Oral Dose of D-1553, a Selective Inhibitor of KRASG12C, in Healthy Chinese Subjects
15天前
已完结
Intracranial Activity of Sotorasib in KRAS G12C -Mutated Recurrent Glioblastoma
15天前
已关闭
Hepatitis B
17天前
已完结
Intracranial Activity of Sotorasib in KRAS G12C -Mutated Recurrent Glioblastoma
18天前
已关闭
Intracranial Activity of Sotorasib in KRAS G12C -Mutated Recurrent Glioblastoma
24天前
已关闭
Design, Structure Optimization, and Preclinical Characterization of JAB-21822, a Covalent Inhibitor of KRASG12C
1个月前
已完结
皖公网安备34019202002308
